Skip to main content
Clinical Trials/ACTRN12618000203257
ACTRN12618000203257
Withdrawn
未知

Effectiveness of a porous titanium and hydroxyapatite plasma-sprayed short stem in total hip arthroplasty.

MAC Surgical0 sites222 target enrollmentFebruary 8, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
MAC Surgical
Enrollment
222
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
MAC Surgical

Eligibility Criteria

Inclusion Criteria

  • Participants with symptomatic arthritis who are candidates for a primary total hip replacement with an uncemented femoral stem as determined jointly by the surgeon and the patient
  • Age \- 75 years or less
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow\-up period

Exclusion Criteria

  • Patients with rheumatoid arthritis
  • Patients with a history of active infection
  • Patients with conditions or medications associated with osteoporosis or osteopenia
  • Pregnant women or those seeking to become pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials